Centessa Pharmaceuticals plc (ADR) share price logo

Centessa Pharmaceuticals plc (ADR)

NASDAQ: CNTA

Mid Cap

$40.55

+0.38

(+0.93%)

as on

Centessa Pharmaceuticals plc (ADR) Stock Performance

as on June 24, 2026 at 6:59 am IST

  • Day's Low

    $40.00
    $40.55
    downward going graph

    1.36%

    Downside

  • 52 Week's Low

    52 Week's High

    $12.39
    $40.26
    downward going graph

    69.45%

    Downside

    -0.72%

    Upside

    downward going graph

Centessa Pharmaceuticals plc (ADR) share price movements today

Previous Close
$40.18
Open
$40.18
Volume
8.6M
Day's Low - High
$40.00 - $40.55
52 Week Low - High
$12.39 - $40.26

Centessa Pharmaceuticals plc (ADR) Historical Returns

1 Month Return
+ 1.08 %
3 Month Return
+ 54.9 %
1 Year Return
+ 209.08 %
3 Year Return
+ 508.79 %
5 Year Return
0 %

Centessa Pharmaceuticals plc (ADR) Stock Fundamentals & Key Indicators

Check Centessa Pharmaceuticals plc (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.2B

EPS (TTM)

-1.56

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-256.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-57.38%

Centessa Pharmaceuticals plc (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Centessa Pharmaceuticals plc (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Centessa Pharmaceuticals plc (ADR) image
Centessa Pharmaceuticals plc (ADR)
BUY$6.2BNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.1B64.01%69.8712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$114.6B148.93%26.835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.9B15.61%14.8829.65%0.59%

Stock Returns calculator for Centessa Pharmaceuticals plc (ADR) Stock including INR - Dollar returns

The Centessa Pharmaceuticals plc (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Centessa Pharmaceuticals plc (ADR) investment value today

Current value as on today

₹3,41,303

Returns

₹2,41,303

(+241.3%)

Returns from Centessa Pharmaceuticals plc (ADR) Stock

₹2,11,923 (+211.92%)

Dollar Impact

₹29,380 (+29.38%)

Analyst Recommendation on Centessa Pharmaceuticals plc (ADR) Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Centessa Pharmaceuticals plc (ADR). Average target price of $44.17

Centessa Pharmaceuticals plc (ADR) Share Price Target

Get share price movements and forecasts by analysts on Centessa Pharmaceuticals plc (ADR).

What analysts predicted

8.2%UPSIDE

Target Price

$44.17

Current Price

$40.55

Analyzed by

11 Analysts

Target

$44.17

Centessa Pharmaceuticals plc (ADR) target price $44.17, a slight upside of 8.2% compared to current price of $40.55. According to 11 analysts rating.

Indian Investors' Interest in Centessa Pharmaceuticals plc (ADR) Stock

Search interest for Centessa Pharmaceuticals plc (ADR) Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Centessa Pharmaceuticals plc (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
6
-
-
-
0
15
-
-
-
-
Gross Profit
6
0
0
0
0
15
0
-
-
0
Operating Income
-35
-36
-43
-46
-74
-30
-54
-53
-68
-79
EBITDA
-32
-34
-40
-39
-107
-21
-46
-51
-87
-75
Interest Expense
2
2
2
2
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-35
-37
-43
-41
-110
-24
-49
-54
-66
-78
Income Tax Expense
1
0
0
0
1
1
0
0
0
0
Net Income
-36
-38
-43
-42
-111
-26
-50
-54
-66
-79
Net Profit Margin
-537.53%
0.00%
0.00%
0.00%
-11691.13%
-174.23%
0.00%
0.00%
0.00%
0.00%

Centessa Pharmaceuticals plc (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
6
-
15
Gross Profit
-
-
0
6
0
15
Operating Income
-5
-10
-212
-171
-201
-207
EBITDA
-5
-10
-209
-165
-221
-183
Interest Expense
0
0
7
9
10
11
Depreciation
0
-
0
0
0
0
Income Before Tax
-5
-10
-216
-176
-232
-195
Income Tax Expense
0
0
0
-25
2
1
Net Income
-5
-10
-216
-151
-235
-197
Net Profit Margin
0.00%
0.00%
0.00%
-2204.65%
0.00%
-1316.88%

Centessa Pharmaceuticals plc (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-38
-38
-42
-111
-26
-50
-54
-66
-79
Operating Cash Flow
-37
-37
-21
-42
-57
-22
-58
-55
-72
Investing Cash Flow
16
-
44
25
-222
-39
61
-218
42
Financing Cash Flow
10
10
245
2
3
1
3
283
30
Change in Cash
-9
-9
267
-11
-278
-60
6
11
1

Centessa Pharmaceuticals plc (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-381
-216
-151
-235
-197
Operating Cash Flow
-10
-136
-200
-160
-142
-193
Investing Cash Flow
63
63
0
-127
31
-418
Financing Cash Flow
1
660
0
21
364
291
Change in Cash
-9
590
-201
-265
255
-321

Global Institutional Holdings in Centessa Pharmaceuticals plc (ADR)

Funds
Holdings
Farallon Capital Management, L.L.C.
3.11%
TCG Crossover Management, LLC
2.77%
First Light Asset Management, LLC
1.01%
Logos Global Management LP
1.37%
Point72 Asset Management, L.P.
1.93%
See all

Centessa Pharmaceuticals plc (ADR) News & Key Events

  • img

    Today's Timeline - 01 April

    Wed, 07:36 PM

    -

    Eli Lilly announces acquisition of Centessa Pharmaceuticals for $38 per share, totaling approximately $6.3 billion.

Insights on Centessa Pharmaceuticals plc (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CNTA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CNTA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, CNTA stock has moved up by 56.5%

About Centessa Pharmaceuticals plc (ADR)

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatment of neurological and neurodegenerative disorders; ORX489 which is in Phase I clinical trial for the treatment of neuropsychiatric disorders; and LockBody, an early-stage immuno-oncology program technology platform. The company was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
OrganisationCentessa Pharmaceuticals plc (ADR)
Headquarters1 Ashley Road, Altrincham, United Kingdom, WA14 2DT
IndustryBiotechnology
CEODr. Mario Alberto Accardi Ph.D.
E-voting on sharesClick here to vote

Key Management of Centessa Pharmaceuticals plc (ADR)

Name

Title

Dr. Gregory M. Weinhoff M.B.A., M.D.

Chief Business Officer

Ms. Charlene Stoudt

Senior Vice President of Clinical Development Operations

Mr. John J. Crowley CPA

Chief Financial Officer

Mr. Raphael Deferiere CPA

Senior VP & Chief Accounting Officer

Ms. Tia L. Bush

Chief Technology & Quality Officer

Mr. Iqbal J. Hussain L.L.B.

Chief Legal Officer, Chief Compliance Officer & Company Secretary

Ms. Karen M. Anderson

Chief People Officer

Dr. Stephen J. Kanes M.D., Ph.D.

Head of R&D and Chief Medical Officer

Dr. Mario Alberto Accardi Ph.D.

CEO & Director

Ms. Kristen K. Sheppard Esq., J.D.

Senior Vice President of Investor Relations & Corporate Communications

FAQs

What is Centessa Pharmaceuticals plc (ADR) share price today?

Centessa Pharmaceuticals plc (ADR) share price today is $40.55 as on at the close of the market. Centessa Pharmaceuticals plc (ADR) share today touched a day high of $40.55 and a low of $40.

What is the 52 week high and 52 week low for Centessa Pharmaceuticals plc (ADR) share?

Centessa Pharmaceuticals plc (ADR) share touched a 52 week high of $40.26 on and a 52 week low of $12.39 on . Centessa Pharmaceuticals plc (ADR) stock price today i.e. is closed at $40.55,which is -0.72% down from its 52 week high and 227.28% up from its 52 week low.

What is Centessa Pharmaceuticals plc (ADR)'s market capitalisation today?

Centessa Pharmaceuticals plc (ADR) market capitalisation is $0.01T as on .

How to invest in Centessa Pharmaceuticals plc (ADR) Stock (CNTA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Centessa Pharmaceuticals plc (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Centessa Pharmaceuticals plc (ADR) Shares that will get you 0.0370 shares as per Centessa Pharmaceuticals plc (ADR) share price of $40.55 per share as on June 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Centessa Pharmaceuticals plc (ADR) Stock (CNTA) from India?

Indian investors can start investing in Centessa Pharmaceuticals plc (ADR) (CNTA) shares with as little as ₹94.735 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.35 in Centessa Pharmaceuticals plc (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Centessa Pharmaceuticals plc (ADR) share’s latest price of $40.55 as on June 24, 2026 at 1:29 am IST, you will get 0.2466 shares of Centessa Pharmaceuticals plc (ADR). Learn more about fractional shares .